| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.2B | $12.7B | $12.3B | $12.6B | $12.4B | $3.2B | $2.7B | $3.4B |
| Cost of Revenue | $9.1B | $8.7B | $8.5B | $8.8B | $8.7B | $7.3B | $6.9B | $9.6B |
| Gross Profit | $4.1B | $4.0B | $3.9B | $3.8B | $3.7B | $0.9B | $0.8B | $0.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.1B | $3.0B | $3.0B | $2.8B | $2.8B | $2.2B | $2.4B | — |
| Operating Income | $0.7B | $0.6B | $0.6B | $0.7B | $0.9B | $0.2B | $0.2B | $0.2B |
| Net Income | $0.4B | $0.4B | $0.4B | $0.5B | $0.6B | $0.4B | $0.3B | $0.1B |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $1.00 | $2.27 | $0.88 |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $0.99 | $2.25 | $0.87 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.2B | $10.2B | $10.6B | $8.6B | $8.5B | $7.8B | $7.2B | $8.5B |
| Current Assets | $4.5B | $4.0B | $4.5B | $4.0B | $3.8B | $3.8B | $3.2B | $4.2B |
| Cash & Equivalents | — | — | — | — | — | — | — | $0.1B |
| Total Liabilities | $6.4B | $5.4B | $5.4B | $3.9B | $3.8B | $3.5B | $3.2B | $4.6B |
| Current Liabilities | $3.2B | $2.8B | $2.7B | $2.2B | $2.3B | $2.3B | $2.0B | $3.2B |
| Stockholders' Equity | $3.2B | $3.4B | $3.7B | $3.4B | $3.4B | $3.3B | $3.0B | $3.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.8B | $0.5B | $0.6B | $0.7B | $0.6B | $0.7B | $0.7B |
| Investing Cash Flow | $-0.4B | $-0.4B | $-1.1B | $-0.3B | $-0.7B | $-0.1B | $-0.4B | $-0.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $-0.5B | $0.7B | $-0.3B | $-0.3B | $-0.2B | $-0.2B | $-0.6B |